{'fraction_non_alphanumeric': 0.02263374485596708, 'fraction_numerical': 0.01440329218106996, 'mean_word_length': 5.324675324675325, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 1, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Quality of life and comorbidity in localized malignant melanoma: results of a German population‐based cohort study

Background  Incidences of malignant melanoma continue to increase in fair‐skinned populations. At least 80% of patients are diagnosed with localized disease and can expect a 5‐year relative survival rate of >90%. Given that the median age at diagnosis of malignant melanoma is 59 years, many patients already suffer chronic diseases when they are confronted with cancer.